Trial of Tolcapone With Oxaliplatin for Neuroblastoma
NCT02630043
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
5
Enrollment
OTHER
Sponsor class
Stopped
Lack of study enrollment
Conditions
Neuroblastoma
Interventions
DRUG:
Tolcapone
DRUG:
Oxaliplatin
Sponsor
Giselle Sholler